美国HIV阴性人群隐球菌病多中心纵向队列研究
多数患者存在免疫抑制,49%有中枢神经系统受累,发热不常见且缺失与诊断延迟相关。尽管接受积极抗真菌治疗,中枢神经系统隐球菌病仍遗留显著长期神经后遗症。
要点
- HIV阴性隐球菌病患者多存在免疫抑制,实体器官移植、自身免疫病和血液恶性肿瘤常见。
- 发热缺失与诊断延迟相关,异常MoCA评分可预测中枢神经系统疾病及长期认知不良。
- 高龄(>60岁)与死亡风险升高相关,而血液恶性肿瘤和既往实体器官移植与较低风险相关。
核心结论
- 尽管接受积极抗真菌治疗,HIV阴性人群中枢神经系统隐球菌病仍以显著长期神经后遗症为特征。
主要发现
- 中枢神经系统疾病见于71例(49%)受试者;发热记录于40例(27.8%)受试者,发热缺失与诊断延迟相关(平均48.2 vs 16.5天;P = .007)。
- 异常MoCA评分(<26)可预测中枢神经系统疾病;低评分(<22)与长期认知不良相关。
- 中枢神经系统疾病患者中25例(35.2%)需要>1次腰椎穿刺,8例(11.3%)需要脑室造瘘。
- 多变量模型中,年龄>60岁与死亡风险升高相关(HR 2.14;95%CI 1.05-4.38;P = .036),血液恶性肿瘤(HR 0.29;95%CI 0.09-0.98;P = .05)和既往实体器官移植(HR 0.153;95%CI 0.05-0.44;P = .001)与较低风险相关。
临床怎么用
- 对HIV阴性但存在免疫抑制的患者应警惕隐球菌病,发热缺失不应排除诊断以避免延迟。
- MoCA评分可用于评估中枢神经系统受累及长期认知预后。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Cryptococcosis is increasingly recognized in people without human immunodeficiency virus (HIV). METHODS: A multicenter, prospective cohort study was performed in 25 US centers. Consenting patients were prospectively followed for ≤2 years. Neurological morbidities were assessed with longitudinal event depiction and functional scores (Montreal Cognitive Assessment [MoCA]). Risks of death were analyzed using Cox regression. RESULTS: One hundred forty-five subjects were enrolled. Most were male (95; 65.5%) and had immunosuppression (120; 82.8%), including solid organ transplant (SOT; 33.8%), autoimmunity (15.9%), and hematologic malignancies (11.7%). Disease involved the central nervous system (CNS) in 71 subjects (49%). Fever was uncommon, documented in 40 (27.8%) subjects, and absence was associated with diagnostic delay (mean: 48.2 vs 16.5 days; P = .007). Abnormal MoCA scores (<26) were predictive of CNS disease; low scores (<22) were associated with poor long-term cognition. Longitudinal event depiction demonstrated frequent complications in people with CNS disease; 25 subjects (35.2%) required >1 lumbar puncture and 8 (11.3%) required ventriculostomies. In multivariable models, older age (>60 years) was associated with higher risks of death (hazard ratio [HR], 2.14; 95% confidence interval [CI], 1.05-4.38; P = .036), and lower risks were noted with underlying hematologic malignancy (HR, 0.29; 95% CI, 0.09-0.98; P = .05) and prior SOT (HR, 0.153; 95% CI, 0.05-0.44; P = .001). CONCLUSIONS: Despite aggressive antifungal therapies, outcomes of CNS cryptococcosis in people without HIV are characterized by substantial long-term neurological sequelae. Studies are needed to understand mechanism(s) of cognitive decline and to enable better treatment algorithms.
引用
- Marr KA, Sun Y, Spec A, et al. A Multicenter, Longitudinal Cohort Study of Cryptococcosis in Human Immunodeficiency Virus-negative People in the United States. Clin Infect Dis. 2020. PMID: 30855688. doi:10.1093/cid/ciz193
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。